ArticleThe oncologist2023

Clinical Treatment Guidelines for Tafasitamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Adrienne Nedved et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.